These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21107787)
1. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. Pniewski T; Kapusta J; Bociąg P; Wojciechowicz J; Kostrzak A; Gdula M; Fedorowicz-Strońska O; Wójcik P; Otta H; Samardakiewicz S; Wolko B; Płucienniczak A J Appl Genet; 2011 May; 52(2):125-36. PubMed ID: 21107787 [TBL] [Abstract][Full Text] [Related]
2. Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. Pniewski T; Kapusta J; Bociąg P; Kostrzak A; Fedorowicz-Strońska O; Czyż M; Gdula M; Krajewski P; Wolko B; Płucienniczak A Plant Cell Rep; 2012 Mar; 31(3):585-95. PubMed ID: 22246107 [TBL] [Abstract][Full Text] [Related]
3. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice. Dobrica MO; Lazar C; Paruch L; van Eerde A; Clarke JL; Tucureanu C; Caras I; Ciulean S; Onu A; Tofan V; Branzan A; Urban S; Stavaru C; Branza-Nichita N Vaccine; 2018 Sep; 36(38):5789-5795. PubMed ID: 30082163 [TBL] [Abstract][Full Text] [Related]
4. Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B. Czyż M; Dembczyński R; Marecik R; Wojas-Turek J; Milczarek M; Pajtasz-Piasecka E; Wietrzyk J; Pniewski T Biomed Res Int; 2014; 2014():485689. PubMed ID: 25371900 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Kostrzak A; Cervantes Gonzalez M; Guetard D; Nagaraju DB; Wain-Hobson S; Tepfer D; Pniewski T; Sala M Vaccine; 2009 Jul; 27(35):4798-807. PubMed ID: 19539581 [TBL] [Abstract][Full Text] [Related]
6. Oral hepatitis B vaccine candidates produced and delivered in plant material. Streatfield SJ Immunol Cell Biol; 2005 Jun; 83(3):257-62. PubMed ID: 15877603 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study. Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369 [TBL] [Abstract][Full Text] [Related]
15. Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. Gao Y; Ma Y; Li M; Cheng T; Li SW; Zhang J; Xia NS World J Gastroenterol; 2003 May; 9(5):996-1002. PubMed ID: 12717845 [TBL] [Abstract][Full Text] [Related]
16. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine. Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297 [TBL] [Abstract][Full Text] [Related]
17. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414 [TBL] [Abstract][Full Text] [Related]
18. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Huang Z; Elkin G; Maloney BJ; Beuhner N; Arntzen CJ; Thanavala Y; Mason HS Vaccine; 2005 Mar; 23(15):1851-8. PubMed ID: 15734055 [TBL] [Abstract][Full Text] [Related]
19. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination. Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781 [TBL] [Abstract][Full Text] [Related]
20. Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen. Hayden CA; Smith EM; Turner DD; Keener TK; Wong JC; Walker JH; Tizard IR; Jimenez-Flores R; Howard JA Vaccine; 2014 Mar; 32(11):1240-6. PubMed ID: 24486361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]